CEO Tina Vidal-Duart says the company will reopen sites if Congress passes funding that covers monoclonal antibody testing or if other sources of funding become available.
All statewide CDR Maguire monoclonal antibody treatment sites will close Thursday at 5p.m. after congress failed to pass more Covid-19 funding the vendor said Thursday in a press release posted to twitter.